Literature DB >> 6150139

An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids.

J Jaeken, G Van den Berghe.   

Abstract

Succinyladenosine and succinylaminoimidazole carboxamide riboside were found in body fluids from 3 children, including a brother and sister, with severe psychomotor delay and autism. Both succinylpurines were identified by acid hydrolysis, anion-exchange chromatography, and ultraviolet spectrophotometry. Concentrations of both compounds were around 100 mumol/l in cerebrospinal fluid, between 5 and 10 mumol/l in plasma, and in the mmol/l range in urine. Succinylpurines were undetectable in cerebrospinal fluid and plasma from controls but there might be trace amounts in normal urine. The compounds are dephosphorylated derivatives of the intracellular metabolites adenylosuccinate and succinylaminoimidazole carboxamide ribotide, the two substrates of adenylosuccinase (adenylosuccinate lyase, EC 4.3.2.2). Their presence indicates a deficiency of this enzyme, which is involved in both de novo synthesis of purines and the formation of adenosine monophosphate from inosine monophosphate. Assays in one patient revealed markedly decreased adenylosuccinase activity in the liver and absence of activity in the kidney. The accumulation of both succinylpurines in the cerebrospinal fluid suggests that there is also a deficiency of this enzyme in the brain and that it may be the basic defect in a subgroup of children with genetically determined autism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150139

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

1.  Mutation of a nuclear respiratory factor 2 binding site in the 5' untranslated region of the ADSL gene in three patients with adenylosuccinate lyase deficiency.

Authors:  S Marie; V Race; M-C Nassogne; M-F Vincent; G Van den Berghe
Journal:  Am J Hum Genet       Date:  2002-05-09       Impact factor: 11.025

2.  Adenylosuccinase deficiency: a newly recognized variant.

Authors:  J Jaeken; F Van den Bergh; M F Vincent; P Casaer; G Van den Berghe
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Developmental disorder associated with increased cellular nucleotidase activity.

Authors:  T Page; A Yu; J Fontanesi; W L Nyhan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Revisiting purine-histidine cross-pathway regulation in Saccharomyces cerevisiae: a central role for a small molecule.

Authors:  Karine Rébora; Benoît Laloo; Bertrand Daignan-Fornier
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

Review 5.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

6.  Stereochemical and regiochemical trends in the selective detection of saccharides.

Authors:  Shan Jiang; Jorge O Escobedo; Kyu Kwang Kim; Onur Alptürk; George K Samoei; Sayo O Fakayode; Isiah M Warner; Oleksandr Rusin; Robert M Strongin
Journal:  J Am Chem Soc       Date:  2006-09-20       Impact factor: 15.419

7.  Purine Biosynthesis Enzymes in Hippocampal Neurons.

Authors:  Julie Williamson; Ronald S Petralia; Ya-Xian Wang; Mark P Mattson; Pamela J Yao
Journal:  Neuromolecular Med       Date:  2017-09-02       Impact factor: 3.843

8.  A new diagnostic technique for adenylosuccinate lyase deficiency.

Authors:  V D Domkin; T A Lazebnik; M N Smirnov
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 9.  When and how does one search for inborn errors of purine and pyrimidine metabolism?

Authors:  H A Simmonds
Journal:  Pharm World Sci       Date:  1994-04-15

Review 10.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.